ZIM Laboratories Limited

NSE ZIMLAB.NS

ZIM Laboratories Limited Return on Capital Employed (ROCE) for the year ending March 31, 2024: 10.53%

ZIM Laboratories Limited Return on Capital Employed (ROCE) is 10.53% for the year ending March 31, 2024, a -40.34% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.
  • ZIM Laboratories Limited Return on Capital Employed (ROCE) for the year ending March 31, 2023 was 17.65%, a 18.17% change year over year.
  • ZIM Laboratories Limited Return on Capital Employed (ROCE) for the year ending March 31, 2022 was 14.93%, a 29.33% change year over year.
  • ZIM Laboratories Limited Return on Capital Employed (ROCE) for the year ending March 31, 2021 was 11.55%, a 84.23% change year over year.
  • ZIM Laboratories Limited Return on Capital Employed (ROCE) for the year ending March 31, 2020 was 6.27%, a -66.56% change year over year.
Key data
Date Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio Return on Common Equity
Market news
Loading...
SV Wall Street
NSE: ZIMLAB.NS

ZIM Laboratories Limited

CEO Dr. Chandrashekhar Mainde
IPO Date Nov. 25, 2022
Location India
Headquarters Sadoday Gyan
Employees 556
Sector Healthcare
Industries
Description

ZIM Laboratories Limited develops, manufactures, and supplies pharmaceutical formulation and pre formulation ingredients in India and internationally. The company provides technology-based drug delivery solutions and non-infringing proprietary manufacturing processes for generic pharmaceutical products in semi-finished and finished categories/formulations, such as granules, pellets, taste masked powders, suspensions, tablets, capsules, and oral thin films. It serves therapeutic areas, such as urology, gastroenterology, cardiology, and anticoagulants, as well as antibiotics and anti-infectives, NSAIDs/pain analgesics, and vitamins and supplements. ZIM Laboratories Limited was incorporated in 1984 and is based in Nagpur, India.

Similar companies

WINDLAS.NS

Windlas Biotech Limited

USD 11.04

-3.01%

YUKEN.NS

Yuken India Limited

USD 9.83

-2.90%

ZOTA.NS

Zota Health Care Limited

USD 10.98

-1.82%

WENDT.NS

Wendt (India) Limited

USD 130.56

-1.26%

XPROINDIA.NS

Xpro India Limited

USD 13.56

-4.07%

StockViz Staff

February 12, 2025

Any question? Send us an email